{"transactions":[{"id":3507078,"issuer":{"id":5993,"kind":"organization","name":"BICYCLE THERAPEUTICS PLC","symbol":"BCYC"},"owners":[{"id":157081,"kind":"person","name":"Anstey Michael","position":1,"cik":"0001776856","reported_name":"Anstey Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series B2 Preferred Shares","published_at":"2019-05-31T01:26:25.000Z","date":"2019-05-28","kind":"exercise","acquired":true,"shares":229741,"ownership":{"direct":false,"nature":"By Cambridge Innovation Capital (Jersey) Limited"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Series B1 and B2 Preferred Share automatically converted into Ordinary Shares on a one-for-1.429 basis upon the closing of the Issuer's initial public offering and had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Series B1 and B2 Preferred Share automatically converted into Ordinary Shares on a one-for-1.429 basis upon the closing of the Issuer's initial public offering and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each Series B1 and B2 Preferred Share automatically converted into Ordinary Shares on a one-for-1.429 basis upon the closing of the Issuer's initial public offering and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each Series B1 and B2 Preferred Share automatically converted into Ordinary Shares on a one-for-1.429 basis upon the closing of the Issuer's initial public offering and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are held by Cambridge Innovation Capital (Jersey) Limited.  The Reporting Person is a member of our Board of Directors and an investment director at Cambridge Innovation Capital plc."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":229741},"source":{"system":"sec-edgar","filing":"0001104659-19-032916","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1761612/000110465919032916/a4.xml","form_type":"4"}},{"id":3507077,"issuer":{"id":5993,"kind":"organization","name":"BICYCLE THERAPEUTICS PLC","symbol":"BCYC"},"owners":[{"id":157081,"kind":"person","name":"Anstey Michael","position":1,"cik":"0001776856","reported_name":"Anstey Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series B1 Preferred Shares Warrants","published_at":"2019-05-31T01:26:25.000Z","date":"2019-05-28","kind":"other","acquired":true,"shares":125587,"ownership":{"direct":false,"nature":"By Cambridge Innovation Capital (Jersey) Limited"},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"Upon conversion of all of the Series B1 Preferred Shares into Ordinary Shares in connection with the Issuer's initial public offering, the Warrants became exercisable for Ordinary Shares. The Warrants had an exercise price of a nominal value per share and were exercised immediately prior to completion of the  Issuer's initial public offering."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Series B1 and B2 Preferred Share automatically converted into Ordinary Shares on a one-for-1.429 basis upon the closing of the Issuer's initial public offering and had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Series B1 and B2 Preferred Share automatically converted into Ordinary Shares on a one-for-1.429 basis upon the closing of the Issuer's initial public offering and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each Series B1 and B2 Preferred Share automatically converted into Ordinary Shares on a one-for-1.429 basis upon the closing of the Issuer's initial public offering and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each Series B1 and B2 Preferred Share automatically converted into Ordinary Shares on a one-for-1.429 basis upon the closing of the Issuer's initial public offering and had no expiration date."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"Each Series B1 and B2 Preferred Share automatically converted into Ordinary Shares on a one-for-1.429 basis upon the closing of the Issuer's initial public offering and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are held by Cambridge Innovation Capital (Jersey) Limited.  The Reporting Person is a member of our Board of Directors and an investment director at Cambridge Innovation Capital plc."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":125587},"source":{"system":"sec-edgar","filing":"0001104659-19-032916","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1761612/000110465919032916/a4.xml","form_type":"4"}},{"id":3507076,"issuer":{"id":5993,"kind":"organization","name":"BICYCLE THERAPEUTICS PLC","symbol":"BCYC"},"owners":[{"id":157081,"kind":"person","name":"Anstey Michael","position":1,"cik":"0001776856","reported_name":"Anstey Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series B1 Preferred Shares","published_at":"2019-05-31T01:26:25.000Z","date":"2019-05-28","kind":"exercise","acquired":true,"shares":1081823,"ownership":{"direct":false,"nature":"By Cambridge Innovation Capital (Jersey) Limited"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Series B1 and B2 Preferred Share automatically converted into Ordinary Shares on a one-for-1.429 basis upon the closing of the Issuer's initial public offering and had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Series B1 and B2 Preferred Share automatically converted into Ordinary Shares on a one-for-1.429 basis upon the closing of the Issuer's initial public offering and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each Series B1 and B2 Preferred Share automatically converted into Ordinary Shares on a one-for-1.429 basis upon the closing of the Issuer's initial public offering and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each Series B1 and B2 Preferred Share automatically converted into Ordinary Shares on a one-for-1.429 basis upon the closing of the Issuer's initial public offering and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are held by Cambridge Innovation Capital (Jersey) Limited.  The Reporting Person is a member of our Board of Directors and an investment director at Cambridge Innovation Capital plc."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":1081823},"source":{"system":"sec-edgar","filing":"0001104659-19-032916","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1761612/000110465919032916/a4.xml","form_type":"4"}},{"id":3507075,"issuer":{"id":5993,"kind":"organization","name":"BICYCLE THERAPEUTICS PLC","symbol":"BCYC"},"owners":[{"id":157081,"kind":"person","name":"Anstey Michael","position":1,"cik":"0001776856","reported_name":"Anstey Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2019-05-31T01:26:25.000Z","date":"2019-05-28","kind":"purchase","acquired":true,"shares":314286,"price":14,"value":4400004.0,"ownership":{"direct":false,"nature":"By Cambridge Innovation Capital (Jersey) Limited"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are held by Cambridge Innovation Capital (Jersey) Limited.  The Reporting Person is a member of our Board of Directors and an investment director at Cambridge Innovation Capital plc."}],"balance_after":1751437,"source":{"system":"sec-edgar","filing":"0001104659-19-032916","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1761612/000110465919032916/a4.xml","form_type":"4"}},{"id":3507074,"issuer":{"id":5993,"kind":"organization","name":"BICYCLE THERAPEUTICS PLC","symbol":"BCYC"},"owners":[{"id":157081,"kind":"person","name":"Anstey Michael","position":1,"cik":"0001776856","reported_name":"Anstey Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2019-05-31T01:26:25.000Z","date":"2019-05-28","kind":"exercise","acquired":true,"shares":229741,"ownership":{"direct":false,"nature":"By Cambridge Innovation Capital (Jersey) Limited"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Series B1 and B2 Preferred Share automatically converted into Ordinary Shares on a one-for-1.429 basis upon the closing of the Issuer's initial public offering and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are held by Cambridge Innovation Capital (Jersey) Limited.  The Reporting Person is a member of our Board of Directors and an investment director at Cambridge Innovation Capital plc."}],"balance_after":1437151,"source":{"system":"sec-edgar","filing":"0001104659-19-032916","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1761612/000110465919032916/a4.xml","form_type":"4"}},{"id":3507073,"issuer":{"id":5993,"kind":"organization","name":"BICYCLE THERAPEUTICS PLC","symbol":"BCYC"},"owners":[{"id":157081,"kind":"person","name":"Anstey Michael","position":1,"cik":"0001776856","reported_name":"Anstey Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2019-05-31T01:26:25.000Z","date":"2019-05-28","kind":"other","acquired":true,"shares":125587,"ownership":{"direct":false,"nature":"By Cambridge Innovation Capital (Jersey) Limited"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Series B1 and B2 Preferred Share automatically converted into Ordinary Shares on a one-for-1.429 basis upon the closing of the Issuer's initial public offering and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are held by Cambridge Innovation Capital (Jersey) Limited.  The Reporting Person is a member of our Board of Directors and an investment director at Cambridge Innovation Capital plc."}],"balance_after":1207410,"source":{"system":"sec-edgar","filing":"0001104659-19-032916","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1761612/000110465919032916/a4.xml","form_type":"4"}},{"id":3507072,"issuer":{"id":5993,"kind":"organization","name":"BICYCLE THERAPEUTICS PLC","symbol":"BCYC"},"owners":[{"id":157081,"kind":"person","name":"Anstey Michael","position":1,"cik":"0001776856","reported_name":"Anstey Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2019-05-31T01:26:25.000Z","date":"2019-05-28","kind":"exercise","acquired":true,"shares":1081823,"ownership":{"direct":false,"nature":"By Cambridge Innovation Capital (Jersey) Limited"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Series B1 and B2 Preferred Share automatically converted into Ordinary Shares on a one-for-1.429 basis upon the closing of the Issuer's initial public offering and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are held by Cambridge Innovation Capital (Jersey) Limited.  The Reporting Person is a member of our Board of Directors and an investment director at Cambridge Innovation Capital plc."}],"balance_after":1081823,"source":{"system":"sec-edgar","filing":"0001104659-19-032916","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1761612/000110465919032916/a4.xml","form_type":"4"}}]}